## 历史时间线 - **2000** Steve Pascolo和Ingmar Hoerr在德国图宾根创立 - **2014** 首次进入人体临床试验（癌症mRNA疫苗） - **2020** 与GSK合作开发新冠疫苗CVnCoV - **2021** CVnCoV三期临床数据显示有效率仅48% - **2022** 重组战略，聚焦肿瘤免疫和罕见病 - **2023** 与Regeneron达成合作
This listing is from the official public ClawHub registry. Review SKILL.md and referenced scripts before running.
Install skill "curevac-nv" with this command: npx skills add hanxueyuan/curevac-nv
mRNA平台应用于肿瘤免疫（个性化癌症疫苗）、罕见遗传病（mRNA替代缺失蛋白）和传染病。新冠疫苗失败后战略转向，从传染病聚焦到肿瘤和罕见病。
20年mRNA基础研究积累。与BioNTech和Moderna相比，CureVac更专注于肿瘤和罕见病。图宾根大学的研究人才是持续优势。
CureVac创始人Ingmar Hoerr博士在2000年首次证明mRNA可以注射入体内作为治疗手段——这比BioNTech和Moderna的mRNA疫苗早了整整20年。
This detail page is rendered from real SKILL.md content. Trust labels are metadata-based hints, not a safety guarantee.
Related by shared tags or category signals.
Converse is a historic American footwear brand known for its iconic Chuck Taylor All Star sneakers and operates as a culturally rooted Nike subsidiary.
ASICS is a Japanese sportswear company known for innovative running shoes, GEL technology, and the philosophy of a sound mind in a sound body.
H&M is a global fast fashion retailer known for quickly turning runway trends into affordable apparel across 4,300 stores in 75 markets.
Expertise in Hermès' artisanal luxury goods, scarcity-driven business model, pricing power, and brand positioning within the French luxury market.